Cholesterol levels and the benefit of statins in heart failure.
Lakoumentas
John A
JA
Cardiology Department, Polyclinic General Hospital, Athens, Greece. johnlakoumentas@yahoo.gr
Dimitroula
Theodora G
TG
Aggeli
Konstantina I
KI
Harbis
Panagiotis K
PK
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D002784:Cholesterol / Q000097:blood*; D006333:Heart Failure / Q000097:blood* / Q000188:drug therapy / Q000453:epidemiology; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D011758:Pyrroles / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D002784:Cholesterol; D000069059:Atorvastatin